GSC The List

Post Reply
Forum Home > S > SCHIZOPHRENIA/ MENTAL DISORDERS*+ 2013-2015

[email protected]
Site Owner
Posts: 1174

Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/

Cannabis and psychosis: what causes what? (full – 2013)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission

Associated with Olanzapine-Induced Weight Gain (full – 2013)

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548

An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid

receptor stimulation on prepulse inhibition regulation and memory in mice (full – 2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full

The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635

Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/acps.12108/full

“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/hup.2312/full

Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/

Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/

What does a mouse tell us about neuregulin 1-cannabis interactions? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/

Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015

CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013) http://link.springer.com/article/10.1007/s00213-012-2839-1

Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966

Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608

Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784

Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21640/abstract

Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023

Peripheral endocannabinoid system dysregulation in first-episode psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23822951

Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614

Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977

Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051

Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663

Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803

The role of cannabinoid 1 receptor expressing interneurons in behavior (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560

Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425

The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750

Cannabidiol as a potential treatment for psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088

High K2 use rate among psych unit patients (news – 2013) http://www.odt.co.nz/news/national/262756/high-k2-use-rate-among-psych-unit-patients

GABA deficits disturb endocannabinoid system (news – 2013) http://www.sciencecodex.com/read/gaba_deficits_disturb_endocannabinoid_system-84784

Cannabis psychosis admissions rose after drug reclassified to Class B (news – 2013) http://www.guardian.co.uk/science/sifting-the-evidence/2013/jul/18/cannabis-psychosis-uk-drug-class-c

Harvard: Marijuana Doesn’t Cause Schizophrenia (news – 2013) http://psychcentral.com/news/2013/12/10/harvard-marijuana-doesnt-cause-schizophrenia/63148.html

Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news – 2013) http://www.examiner.com/article/can-the-cannabis-component-cannabidiol-cbd-cure-schizophrenia?cid=PROD-redesign-right-next

The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full

CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain

neurotensin (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/

Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full – 2014) http://jpn.ca/wp-content/uploads/2014/12/39-6-140081.pdf

Cannabinoids and schizophrenia: therapeutic prospects (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368

A controlled family study of cannabis users with and without psychosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24309013

Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217

Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285

Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871

Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061

Genetic predisposition to schizophrenia associated with increased use of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24957864

Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234

Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427

Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25176118

Cannabis use and suicidal ideations in high-school students (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343

Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25253856

Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292

The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117

Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937

Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522381

Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541

Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491

Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25539511

The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce anti-psychotic effects (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.13000/abstract

Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news – 2014) (requires free registration) http://www.fool.com/investing/general/2014/09/13/is-medical-marijuana-destined-to-become-a-topschi.aspx

Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug's harm to children and adults, but the scientific evidence is seldom clear-cut (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full

Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398

Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25618402

Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page – 2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite_Related.14.aspx

Marijuana Could Be the Answer to Fighting These 3 Diseases (news – 2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx

March 28, 2015 at 8:06 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.